Peptide inhibitors use two related mechanisms to alter the apparent calcium affinity of the sarcoplasmic reticulum calcium pump

Biochemistry

Volumn 47, Issue 36, 2008, Pages 9522-9530

  Afara, Michael R ^a   Trieber, Catharine A ^a   Ceholski, Delaine K ^a   Young, Howard S ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATION ANALYSIS; AMINES;

PEPTIDE INHIBITORS; RATIONAL DESIGN; SARCOPLASMIC RETICULUM;

CALCIUM;

PEPTIDE DERIVATIVE; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE;

AMINO ACID SEQUENCE; ARTICLE; HYDROPHOBICITY; KINETICS; MOLECULAR MODEL; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN SYNTHESIS; PROTEOLIPOSOME; SIMULATION;

ANIMALS; CALCIUM; CALCIUM-BINDING PROTEINS; COMPUTER SIMULATION; ENZYME ACTIVATION; ENZYME INHIBITORS; HYDROPHOBICITY; ION TRANSPORT; MODELS, MOLECULAR; PEPTIDES; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; RABBITS; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES;

EID: 51549118890     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi800880q     Document Type: Article

References (47)

1. Kirchberger, M., Tada, M., and Katz, A. (1975) Phospholamban: a regulatory protein of the cardiac sarcoplasmic reticulum. Recent Adv. Stud. Cardiac Struct. Metab. 5, 103-115.
2. 2+ concentration, and of an adenosine-3′,5′- monophosphate-dependent protein kinase. Recent Adv. Stud. Cardiac Struct. Metab. 4, 427-436.
3. Cantilina, T., Sagara, Y., Inesi, G., and Jones, L. R. (1993) Comparative studies of cardiac and skeletal sarcoplasmic reticulum ATPases: effect of phospholamban antibody on enzyme activation. J. Biol. Chem. 268, 17018-17025.
4. Simmerman, H. K. B., Collins, J. H., Theibert, J. L., Wegener, A. D., and Jones, L. R. (1986) Sequence analysis of phospholamban: identification of phosphorylation sites and two major structural domains. J. Biol. Chem. 261, 13333-13341.
5. Lamberth, S., Schmid, H., Muenchbach, M., Vorherr, T., Krebs, J., Carafoli, E., and Griesinger, C. (2000) NMR solution structure of phospholamban. Helv. Chim. Acta 83, 2141-2152.
6. Zamoon, J., Mascioni, A., Thomas, D. D., and Veglia, G. (2003) NMR solution structure and topological orientation of monomeric phospholamban in dodecylphosphocholine micelles. Biophys. J. 85, 2589-2598.
7. Oxenoid, K., and Chou, J. (2005) The structure of phospholamban pentamer reveals a channel-like architecture in membranes. Proc. Natl. Acad. Sci. U.S.A. 102, 10870-10875.
8. 2+-ATPase-bound phospholamban in lipid bilayers by solid-state nuclear magnetic resonance (NMR) spectroscopy. Biochemistry 47, 4369-4376.
9. 2+-ATPase of sarcoplasmic reticulum. J. Biol. Chem. 269, 3088-3094.
10. Sharma, P., Patchell, V. B., Gao, Y., Evans, J. S., and Levine, B. A. (2001) Cytoplasmic interactions between phospholamban residues 1-20 and the calcium-activated ATPase of the sarcoplasmic reticulum. Biochem. J. 355, 699-706.
11. 2+ pump revealed by intermolecular thiol cross-linking. J. Biol. Chem. 277, 28319-28329.
12. 2+ pump revealed with use of heterobifunctional cross-linking agents. J. Biol. Chem. 278, 48348-48356.
13. 2+-ATPase isoform of cardiac sarcoplasmic reticulum. J. Biol. Chem. 273, 14238-14241.
14. 2+-ATPase through intramembrane interactions. J. Biol. Chem. 271, 21726-21731.
15. Karim, C. B., Marquardt, C. G., Stamm, J. D., Barany, B., and Thomas, D. D. (2000) Synthetic null-cysteine phospholamban analogue and the corresponding transmembrane domain inhibit the Ca-ATPase. Biochemistry 39, 10892-10897.
16. Afara, M., Trieber, C., Glaves, J., and Young, H. (2006) Rational design of peptide inhibitors of the sarcoplasmic reticulum calcium pump. Biochemistry 45, 8617-8627.
17. Simmerman, H. K. B., Kobayashi, Y. M., Autry, J. M., and Jones, L. R. (1996) A leucine zipper stabilizes the pentameric membrane domain of phospholamban and forms a coiled-coil pore structure. J. Biol. Chem. 271, 5941-5946.
18. Kimura, Y., Kurzydlowski, K., Tada, M., and MacLennan, D. H. (1997) Phospholamban inhibitory function is enhanced by depolymerization. J. Biol. Chem. 272, 15061-15064.
19. 2+ pump and phospholamban in Spodoptera frugiperda (Sf21) cells reveals new insights on ATPase regulation. J. Biol. Chem. 272, 15872-15880.
20. 2+-pump of cardiac sarcoplasmic reticulum. J. Biol. Chem. 275, 41487-41494.
21. 2+ ATPase. Proc. Natl. Acad. Sci. U.S.A. 100, 467-472.
22. 2+ pump of cardiac sarcoplasmic reticulum to probe spatial and functional interactions within the transmembrane domain. J. Biol. Chem. 281, 14163-14172.
23. 2+ pump of cardiac sarcoplasmic reticulum. J. Biol. Chem. 280, 10530-10539.
24. 2+. Proc. Natl. Acad. Sci. U.S.A. 102, 14489-14496.
25. Toyoshima, C., and Nomura, H. (2002) Structural changes in the calcium pump accompanying the dissociation of calcium. Nature 418, 605-611.
26. Trieber, C. A., Douglas, J., Afara, M., and Young, H. S. (2005) The effects of mutation on the regulatory properties of phospholamban in co-reconstituted membranes. Biochemistry 44, 3289-3297.
27. Choma, C., Gratkowski, H., Lear, J. D., and DeGrado, W. F. (2000) Asparagine-mediated self-association of a model transmembrane helix. Nat. Struct. Biol. 7, 161-166.
28. Zhou, F. X., Merianos, H. J., Brunger, A. T., and Engelman, D. M. (2001) Polar residues drive association of polyleucine transmembrane helices. Proc. Natl. Acad. Sci. U.S.A. 98, 2250-2255.
29. Goldstein, J., Lehnhardt, S., and Inouye, M. (1991) In vivo effect of asparagine in the hydrophobic region of the signal sequence. J. Biol. Chem. 266, 14413-14417.
30. Warren, G. B., Toon, P. A., Birdsall, N. J. M., Lee, A. G., and Metcalfe, J. C. (1974) Reconstitution of a calcium pump using defined membrane components. Proc. Natl. Acad. Sci. U.S.A. 71, 622-626.
31. 2-amide. Biochemistry 34, 2348-2361.
32. Eletr, S., and Inesi, G. (1972) Phospholipid orientation in sarcoplasmic reticulum membranes: spin-label ESR and proton NMR studies. Biochim. Biophys. Acta 282, 174-179.
33. Stokes, D. L., and Green, N. M. (1990) Three-dimensional crystals of Ca-ATPase from sarcoplasmic reticulum: symmetry and molecular packing. Biophys. J. 57, 1-14.
34. 2+-ATPase. Biophys. J. 72, 2545-2558.
35. Chen, P. S., Toribara, T. Y., and Warner, H. (1956) Microdetermination of phosphorous. Anal. Chem. 28, 1756-1758.
36. Chester, D. W., Herbette, L. G., Mason, R. P., Joslyn, A. F., and Triggle, D. J. (1987) Diffusion of dihydropyridine calcium channel antagonists in cardiac sarcolemmal lipid multibilayers. Biophys. J. 52, 1021-1030.
37. Markwell, M. H., Hass, S. M., Beiber, L. L., and Tolbert, N. E. (1978) A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal. Biochem. 87, 206-210.
38. Kuzmic, P. (1996) Program DYNAFIT for the analysis of enzyme kinetic data: application to HIV Proteinase. Anal. Biochem. 237, 260-273.
39. McRee, D. E. (1999) XtalView/Xfit-A versatile program for manipulating atomic coordinates and electron density. J. Struct. Biol. 125, 156-165.
40. 2+-ATPase and the pentameric form of phospholamban in two-dimensional co-crystals. Biophys.l J. 90, 4213-4223.
41. 2+-ATPase: mechanisms of membrane protein insertion into liposomes during reconstitution procedures involving detergents. Biochim. Biophys. Acta 1107, 283-298.
42. Reddy, L. G., Cornea, R. L., Winters, D. L., McKenna, E., and Thomas, D. D. (2003) Defining the molecular components of calcium transport regulation in a reconstituted membrane system. Biochemistry 42, 4585-4592.
43. Ferrington, D., Yao, Q., Squier, T., and Bigelow, D. (2002) Comparable levels of Ca-ATPase inhibition by phospholamban in slow-twitch skeletal and cardiac sarcoplasmic reticulum. Biochemistry 41, 13289-13296.
44. 2+-ATPase and phospholamban in High-Five cells. Protein Expression Purif. 34, 56-67.
45. 2-amide with phosphatidylcholine bilayers. Biochemistry 34, 2362-2371.
46. Antipenko, A. Y., Spielman, A. I., Sassaroli, M., and Kirchberger, M. A. (1997) Comparison of the kinetic effects of phospholamban phosphorylation and anti-phospholamban monoclonal antibody on the calcium pump in purified cardiac sarcoplasmic reticulum membranes. Biochemistry 36, 12903-12910.
47. 2+, but not by phospholamban phosphorylation, vanadate, or thapsigargin, and are enhanced by ATP. J. Biol. Chem. 275, 15034-15038.